Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1987-06-16
1989-01-03
Schenkman, Leonard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
A61K 3156
Patent
active
047957476
ABSTRACT:
16-epiestriol as an anti-inflammatory drug.
REFERENCES:
Amer. J. Med. (1983) No. 74, pp. 957-960, article by N. S. Latman.
Hilgar et al from Issue 3, Jun. 1968 from Uterotropic, "Endocyine Bioassoy Data:", Entry Nos. 4324-5902, Part VI, pp. 1-33.
Korenman, Steroids, 13(2):163-177, 1969.
Thomas et al, "Principles of Endocrine Pharmacology", Plenum Medical Book Co., New York, 1986.
Taber's Cyclopedic Medical Dictionary, 15th Edition, p. 576, F. A. Davis Company.
P. H. Jellinck, Bio Chemistry, An Introduction, pp. 280-281, Rinehart and Winston.
Cantarow et al, Biochemistry, Fourth Edition, 1967, p. 689, W. B. Saunders Company.
E. J. W. Barrington, An Introduction to General and Comparative Endocrinology, Second Edition, 1975, p. 111, Clarendon Press.
D. Norris, Vertebrate Endocrinology, Second Edition, 1985, Chapter 9, Lea & Febriger.
R. Chaudhury, Pharmacology of Estrogens, Section 106, pp. 1, 19 and 49, Pergamon Press.
J. Brobeck, Best & Taylor's Physiological Basis of Medical Practice, Tenth Edition, Chapter 10, pp. 7-113, Williams & Wilkins.
E. Selkurt, Physiology, Fifth Edition, p. 651, Little, Brown and Company.
"Dorland's Medical Dictionary", 27th Edition, 1968, p. 584, W. B. Saunders Company.
"Drug Information 86", published by authority of the Board of Directors of the American Society of Hospital Pharmacists, 68:16 Estrogens, p. 1543.
F. Strand, Physiology, A Regulatory Systems Approach, Second Edition, Chapter 25, p. 577, Macmillan Publishing Co.
Merck Index, 10th edition, 1983, entry 3654.
Brandely et al, Biomed. 36:308 (1982).
Espey, L. L., Biol, Reprod. 22:73 (1980).
Siiteri, et al, Ann. N.Y. Acad. Sci, 286:384 (1977).
Ishioka, et al, Acta Endocr. 60:177 (1969).
Toivanen, et al, Med. Pharmacol, Exp. 17:33 (1967).
Hanes, et al, Chapter 63 "The Pharmacol. Basis of Therapeutics", Seventh Ed., MacMillan Publishing Co., N.Y. (1985).
Bruot Brent C.
Kishore Vimal
Latman Neal S.
Flanders Harold H.
Lipovsky Joseph A.
Price Robert L.
Schenkman Leonard
LandOfFree
16-epiestriol to prevent, inhibit or reduce inflammation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 16-epiestriol to prevent, inhibit or reduce inflammation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 16-epiestriol to prevent, inhibit or reduce inflammation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2168629